0	10	Expression	expression	NN
11	13	of	of	IN
14	32	erythroid-specific	erythroid-specific	JJ
33	38	genes	gene	NNS
39	41	in	in	IN
42	58	megakaryoblastic	megakaryoblastic	JJ
59	68	disorders	disorder	NNS
68	69	.	.	.

71	80	Currently	currently	RB
81	90	available	available	JJ
91	95	data	datum	NNS
96	104	indicate	indicate	VBP
105	109	that	that	IN
110	119	erythroid	erythroid	JJ
120	123	and	and	CC
124	138	megakaryocytic	megakaryocytic	JJ
139	154	differentiation	differentiation	NN
155	163	pathways	pathway	NNS
164	167	are	be	VBP
168	175	closely	closely	RB
176	183	related	related	JJ
184	186	to	to	TO
187	191	each	each	DT
192	197	other	other	JJ
197	198	,	,	,
199	202	and	and	CC
203	208	there	there	EX
209	212	may	may	MD
213	218	exist	exist	VB
219	229	progenitor	progenitor	NN
230	235	cells	cell	NNS
236	242	common	common	JJ
243	245	to	to	TO
246	251	those	those	DT
252	255	two	two	CD
256	264	lineages	lineage	NNS
265	268	may	may	MD
269	274	exist	exist	VB
274	275	.	.	.

276	281	Acute	acute	JJ
282	298	megakaryoblastic	megakaryoblastic	JJ
299	307	leukemia	leukemia	NN
308	309	(	(	(
309	315	AML-M7	AML-M7	NNP
315	316	)	)	)
317	320	and	and	CC
321	330	transient	transient	JJ
331	349	myeloproliferative	myeloproliferative	JJ
350	358	disorder	disorder	NN
359	361	in	in	IN
362	366	Down	Down	NNP
366	368	’s	's	POS
369	377	syndrome	syndrome	NN
378	379	(	(	(
379	382	TMD	TMD	NNP
382	383	)	)	)
384	387	are	be	VBP
388	401	characterized	characterize	VBN
402	404	by	by	IN
405	410	rapid	rapid	JJ
411	417	growth	growth	NN
418	420	of	of	IN
421	429	abnormal	abnormal	JJ
430	435	blast	blast	NN
436	441	cells	cell	NNS
442	447	which	which	WDT
448	455	express	express	VBP
456	470	megakaryocytic	megakaryocytic	JJ
471	478	markers	marker	NNS
478	479	.	.	.

480	485	These	these	DT
486	491	blast	blast	NN
492	497	cells	cell	NNS
498	505	express	express	VBP
506	522	lineage-specific	lineage-specific	JJ
523	536	transcription	transcription	NN
537	544	factors	factor	NNS
545	549	such	such	JJ
550	552	as	as	IN
553	559	GATA-1	gata-1	NN
560	566	common	common	JJ
567	569	to	to	TO
570	575	these	these	DT
576	584	lineages	lineage	NNS
585	588	and	and	CC
589	599	frequently	frequently	RB
600	607	express	express	VBP
608	626	erythroid-specific	erythroid-specific	JJ
627	632	mRNAs	mrna	NNS
633	637	such	such	JJ
638	640	as	as	IN
641	653	gamma-globin	gamma-globin	NN
654	657	and	and	CC
658	667	erythroid	erythroid	JJ
668	689	delta-aminolevulinate	delta-aminolevulinate	NN
690	698	synthase	synthase	NN
699	700	(	(	(
700	706	ALAS-E	ALAS-E	NNP
706	707	)	)	)
707	708	,	,	,
709	719	indicating	indicate	VBG
720	724	that	that	IN
725	729	most	most	JJS
730	732	of	of	IN
733	736	the	the	DT
737	743	blasts	blast	NNS
744	746	in	in	IN
747	749	M7	M7	NNP
750	753	and	and	CC
754	757	TMD	TMD	NNP
758	763	cases	case	NNS
764	768	have	have	VBP
769	778	erythroid	erythroid	JJ
779	782	and	and	CC
783	797	megakaryocytic	megakaryocytic	JJ
798	808	phenotypes	phenotype	NNS
808	809	.	.	.

810	815	These	these	DT
816	823	results	result	NNS
824	831	suggest	suggest	VBP
832	836	that	that	IN
837	843	blasts	blast	NNS
844	846	in	in	IN
847	849	M7	M7	NNP
850	853	and	and	CC
854	857	TMD	TMD	NNP
858	861	may	may	MD
862	872	correspond	correspond	VB
873	875	to	to	TO
876	887	progenitors	progenitor	NNS
888	890	of	of	IN
891	895	both	both	CC
896	905	erythroid	erythroid	JJ
906	909	and	and	CC
910	924	megakaryocytic	megakaryocytic	JJ
925	933	lineages	lineage	NNS
933	934	.	.	.